[HTML][HTML] Low-dose decitabine monotherapy reverses mixed chimerism in adult patients after allogeneic hematopoietic stem cell transplantation with myeloablative …
L Wang, LN Wang, JF Zhou, WH Gao, CH Jiang… - Frontiers in …, 2021 - frontiersin.org
T cell mixed chimerism (MC) after allogeneic hematopoietic stem cell transplantation (allo-
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative …
L Wang, LN Wang, JF Zhou, WH Gao… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
T cell mixed chimerism (MC) after allogeneic hematopoietic stem cell transplantation (allo-
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
[HTML][HTML] Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With …
L Wang, L Wang, J Zhou, W Gao, C Jiang… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
T cell mixed chimerism (MC) after allogeneic hematopoietic stem cell transplantation (allo-
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
Low-Dose Decitabine Monotherapy Reverses Mixed Chimerism in Adult Patients After Allogeneic Hematopoietic Stem Cell Transplantation With Myeloablative …
L Wang, LN Wang, JF Zhou, WH Gao, CH Jiang… - Frontiers in …, 2021 - europepmc.org
T cell mixed chimerism (MC) after allogeneic hematopoietic stem cell transplantation (allo-
HSCT) with myeloablative conditioning for hematological malignancies may indicate …
HSCT) with myeloablative conditioning for hematological malignancies may indicate …